Trump Nominates Former Drug Company Executive as HHS Secretary

HeadlineNov 14, 2017
 h04 pharma hhs

President Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price. Public Citizen’s Robert Weissman criticized the nomination, saying, “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Up arrowTop